‘Serum’s pneumococcal vaccine will be available by June 2020’
Serum Institute is optimistic that its pneumococcal vaccine will be available in India by June 2020. The vaccine is yet to be approved by the DCGI. But phase-3 trial data…
Category: Clinical trial
WHO prequalifies Serum’s low-cost pneumococcal vaccine
WHO has prequalified Pune-based Serum Institute’s pneumococcal conjugate vaccine made of 10 serotypes that are widely prevalent and cause pneumonia in Latin America, Africa and Asia. The vaccine will cost…
Deadly Ebola virus on the brink of being tamed
Preliminary analysis of 499 Ebola infected participants has sprung a surprise — the chances of survival may be as high as 90% if patients are treated with one of the…
Explainer: Why is China laying down gene editing rules?
Dr. He’s experiment violates the 2003 guidelines that prohibits the use of gene-manipulated embryos for reproductive purposes. China has posted the draft regulation requiring researchers to obtain prior approval from…
‘Unethical to withhold bedaquiline treatment while waiting for Phase III results’
In a Phase IIb trail, bedaquiline drug for MDR-TB treatment was found to be cardiotoxic and hepatotoxic, and it also caused more deaths. Review of evidence in 2015 showed a…
ICMR wins the 2017 Kochon Prize for TB research
The Indian Council of Medical Research (ICMR) has won the Stop TB Kochon Prize for excellence in TB research and development. The $65,000 Prize is awarded annually by Stop TB Partnership to individuals and/or…
WHO revises advice on use of delamanid drug in MDR-TB patients
In a Phase III trial, delamanid drug was found to be safe but the cure rate and mortality rate were not different between the group that received the delamanid drug…
Growing interest in HPV vaccination in India
Delhi and Punjab have introduced HPV vaccination and are expanding it, while a few States have shown interest. And the National Technical Advisory Group on Immunisation is considering the introduction…
